Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Gains from Investment Securities (2020 - 2025)

Privia Health (PRVA) has 6 years of Gains from Investment Securities data on record, last reported at -$1.5 million in Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 754.78% year-over-year to -$1.5 million; the TTM value through Dec 2025 reached $326000.0, down 91.32%, while the annual FY2025 figure was $326000.0, 91.32% down from the prior year.
  • Gains from Investment Securities reached -$1.5 million in Q4 2025 per PRVA's latest filing, down from $1.8 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $9.2 million in Q4 2021 and bottomed at -$7.6 million in Q4 2022.
  • Average Gains from Investment Securities over 5 years is $776555.6, with a median of -$103500.0 recorded in 2023.
  • Peak YoY movement for Gains from Investment Securities: surged 6697.25% in 2021, then plummeted 754.78% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $9.2 million in 2021, then plummeted by 182.36% to -$7.6 million in 2022, then soared by 100.3% to $23000.0 in 2023, then soared by 900.0% to $230000.0 in 2024, then plummeted by 754.78% to -$1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were -$1.5 million in Q4 2025, $1.8 million in Q2 2025, and $230000.0 in Q4 2024.